Journal of magnetic resonance imaging : JMRI
-
J Magn Reson Imaging · Aug 2017
Patient-specific 3D FLAIR for enhanced visualization of brain white matter lesions in multiple sclerosis.
To improve the conspicuity of white matter lesions (WMLs) in multiple sclerosis (MS) using patient-specific optimization of single-slab 3D fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI). ⋯ 1 Technical Efficacy: Stage 1 J. MAGN. RESON. IMAGING 2017;46:557-564.
-
J Magn Reson Imaging · Aug 2017
Within- and between-session reproducibility of GABA measurements with MR spectroscopy.
The reproducibility of the MEGA-PRESS (MEshcher-GArwood Point RESolved Spectroscopy) MR spectroscopy sequence for the measurement of gamma- aminobutyric acid (GABA) is addressed, focusing on optimizing the number of repetitions at two voxel locations in the human brain and associated possibilities in analysis tools. ⋯ 1 Technical Efficacy: Stage 1 J. MAGN. RESON. IMAGING 2017;46:421-430.
-
J Magn Reson Imaging · Aug 2017
Comparative StudyComparative T2 and T1ρ mapping of patellofemoral cartilage under in situ mechanical loading with prospective motion correction.
To demonstrate improved T2 and T1ρ mapping of patellofemoral cartilage with in situ loading by means of prospective motion correction and to assess load-induced changes in healthy subjects. ⋯ 3 Technical Efficacy: Stage 1 J. MAGN. RESON. IMAGING 2017;46:452-460.
-
J Magn Reson Imaging · Aug 2017
Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI.
To present and quantify the performance of a method to compute tissue hemodynamic parameters from dynamic susceptibility contrast (DSC) MRI data in brain tissue with possible nonintact blood-brain barrier. ⋯ 3 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:537-549.
-
J Magn Reson Imaging · Aug 2017
Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
To enhance the visibility of nigrosome 1 in substantia nigra, which has recently been suggested as an imaging biomarker for Parkinson's disease (PD) at 3T magnetic resonance imaging (MRI). ⋯ 3 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:528-536.